Document is current
Any future updates will be listed below
-
Authors
Fisch, Daniel https://orcid.org/0000-0002-8155-0367
Zhang, Tian
Sun, He
Ma, Weiyi https://orcid.org/0009-0002-2290-8725
Tan, Yunhao https://orcid.org/0000-0002-5516-4980
Gygi, Steven P. https://orcid.org/0000-0001-7626-0034
Higgins, Darren E. https://orcid.org/0000-0003-0562-1300
Kagan, Jonathan C. https://orcid.org/0000-0003-2364-2746
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 28 May 2024
First Online: 3 July 2024
Change Date: 11 July 2024
Change Type: Update
Change Details: In the version of the article initially published, Fig. 3c erroneously included the number “2” in the top right image, which has now been removed in the HTML and PDF versions of the article.
Competing interests
: J.C.K. consults and holds equity in Corner Therapeutics, Larkspur Biosciences, MindImmune Therapeutics and Neumora Therapeutics. None of these relationships impacted this study. The other authors declare no competing interests.
